Efficacy of Fractional CO2 Laser Treatment for Genitourinary Syndrome of Menopause in Short-Term Evaluation—Preliminary Study
article
OA: gold
CC0
AI-generated summary
Fractional CO2 laser treatment improved vaginal pH, VHIS, VMI, and FSFI scores in postmenopausal women with genitourinary syndrome, with high patient satisfaction.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
The postmenopausal state covers 40% of modern women’s lives and 50–70% of postmenopausal women report GSM symptoms such as vaginal dryness, itching, frequent inflammations, lack of elasticity, or dyspareunia. Consequently, a safe and effective method of treatment is crucial. In a group of 125 patients, a prospective observational study was performed. The aim was to evaluate the clinical effectiveness of fractional CO2 laser in the treatment of GSM symptoms using a protocol of three procedures in 6-week intervals. The vaginal pH, VHIS, VMI, FSFI, and treatment satisfaction questionnaire were used. The fractional CO2 laser treatment was effective in improving all the objective forms of evaluation: vaginal pH (from 5.61 ± 0.50 at the baseline up to 4.69 ± 0.21 in the 6-week follow-up after the third procedure); VHIS (12.02 ± 1.89 at the baseline vs. 21.50 ± 1.76); VMI (21.5 ± 5.66 vs. 48.4 ± 4.46). Similar results were obtained for FSFI: 12.79 ± 5.351 vs. 24.39 ± 2.733, where 79.77% of patients were highly satisfied. Fractional CO2 laser therapy increases the quality of life by having a beneficial effect on the sexual function of women with GSM symptoms. This effect is obtained by restoring the correct structure and proportions of the cellular composition of the vaginal epithelium. This positive effect was confirmed by both objective and subjective forms of evaluating GSM symptom severity.
My notes (saved in your browser only)
Condition tags
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (3)
References (62)
- Chronic pelvic pain via openalex
- Fractional CO2 Laser Treatment of the Vestibule for Patients with Vestibulodynia and Genitourinary Syndrome of Menopause: A Pilot Study via openalex
- Microablative fractional CO2 laser for the genitourinary syndrome of menopause: up to 12-month results via openalex
- W1508654241 via openalex
- W1975348491 via openalex
- W1996202707 via openalex
- W2008092721 via openalex
- W2012245090 via openalex
- W2023746334 via openalex
- W2070506018 via openalex
- W2079959631 via openalex
- W2100392631 via openalex
- W2104641268 via openalex
- W2107186198 via openalex
- W2112997260 via openalex
- W2121344236 via openalex
- W2130723294 via openalex
- W2141690791 via openalex
- W2478055203 via openalex
- W2486164693 via openalex
- W2514276915 via openalex
- W2520858269 via openalex
- W2588239035 via openalex
- W2590974405 via openalex
- W2615205819 via openalex
- W2615266986 via openalex
- W2738474727 via openalex
- W2748616939 via openalex
- W2750436905 via openalex
- W2753501880 via openalex
- W2786496762 via openalex
- W2793680153 via openalex
- W2794063291 via openalex
- W2800601012 via openalex
- W2904173781 via openalex
- W2906900895 via openalex
- W2911934775 via openalex
- W2955648917 via openalex
- W2970171547 via openalex
- W2978603081 via openalex
- W3000367249 via openalex
- W3015637762 via openalex
- W3020636412 via openalex
- W3201811455 via openalex
- W4210641244 via openalex
- W4224287165 via openalex
- W4244853583 via openalex
- W4249555636 via openalex
- W4282041339 via openalex
- W4293032859 via openalex
- W4300188711 via openalex
- W6608037814 via openalex
- W6643747033 via openalex
- W6679351675 via openalex
- W6722438441 via openalex
- W6748315700 via openalex
- W6775905616 via openalex
- W6785128388 via openalex
- W196711160 via openalex
- W6844359710 via openalex
- W1129808422 via openalex
- W1197077700 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK